A comparison of incidences of vertebral fracture in Japanese patients with osteoporosis treated with Etidronate and alfacalcidol; a randomized, double-blind study
Phase 4
- Conditions
- Primary osteoporosis
- Registration Number
- JPRN-jRCT1080220091
- Lead Sponsor
- Dainippon Sumitomo Pharma Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
-Primary osteoporosis
-Patient who had none or one to four vertebral (T4-L5) fracture(s)
-Menopausal or postmenopausal woman or man aged 50 to less than 77
-Patients who can walk (hospitalization/outpatient)
etc.
-Secondary osteoporosis
-Other diseases with reduced bone mass except secondary osteoporosis
-Radiographic finding that might affect the vertebral intensity
etc.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy: Incidences of vertebral fracture, etc.
- Secondary Outcome Measures
Name Time Method